PharmaShots | Incisive News in 3 Shots

Subscribe Now

Regulatory

Hansa Biopharma Receives Positive Reimbursement Decision for Idefirix (imlifidase) in the Czech Republic

Hansa Biopharma Receives Positive Reimbursement Decision for Idefirix (imlifidase) in the Czech Republic

January 2, 2023

DePuy (J&J)’s Teligen System Receives the US FDA Approval for User-Centric Procedural Control During Spine Surgery

DePuy (J&J)’s Teligen System Receives the US FDA Approval for User-Centric Procedural Control During Spine Surgery

October 21, 2022

AbbVie’s Rinvoq (upadacitinib) Receives EC’s Approval as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

AbbVie’s Rinvoq (upadacitinib) Receives EC’s Approval as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloa...

July 29, 2022

NICE Publishes Final Recommendation for Novartis’ Piqray and Gilead’s Trodelvy to Treat Breast Cancer

NICE Publishes Final Recommendation for Novartis’ Piqray and Gilead’s Trodelvy to Treat Breast Cancer

July 14, 2022

Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval as an Adjuvant Therapy for Renal Cell Carcinoma

Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval as an Adjuvant Therapy for Renal Cell Carcinoma

November 19, 2021

Antengene's Selinexor (ATG-010) Receives NMPA's IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Antengene's Selinexor (ATG-010) Receives NMPA's IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

November 19, 2021

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us